TD Securities cut shares of Trilogy International Partners (TSE:TRL) from a buy rating to a hold rating in a report issued on Friday. The brokerage currently has C$6.00 price target on the specialty pharmaceutical company’s stock, down from their previous price target of C$7.00.
Separately, Scotiabank reaffirmed an outperform rating and set a C$9.50 price target on shares of Trilogy International Partners in a report on Thursday, December 7th.
Shares of Trilogy International Partners (TRL) opened at C$4.95 on Friday. Trilogy International Partners has a twelve month low of C$4.95 and a twelve month high of C$10.02. The firm has a market cap of $305.41 and a P/E ratio of -0.04.
About Trilogy International Partners
Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.
Receive News & Ratings for Trilogy International Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners and related companies with MarketBeat.com's FREE daily email newsletter.